RWE: Data-driven growth attracting investors

Following a number of recent transactions in the space, PMSI share insights on the RWD/RWE landscape.

Our key insights:

  • In the last few years, Digital Health solutions have seen rapid adoption driven in part by greater value placed on healthcare post-COVID – as governments and corporations aim to generate more value from the data inherent within healthcare systems worldwide
  • Real World Data (RWD) and Evidence (RWE) solutions in particular have seen strong interest due to growing regulatory support and patient data availability, as well as a shift towards performance-based contracts alongside Pharma investment into advanced data analytics
  • As a result, what has traditionally been a space for venture capital is increasingly attracting private equity and other later-stage investors as they seek to own datasets underlying the shift towards a more digital healthcare system

Read the full article below: